Paula Silverman

3.6k total citations
60 papers, 1.6k citations indexed

About

Paula Silverman is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paula Silverman has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 24 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paula Silverman's work include Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (20 papers) and Advanced Breast Cancer Therapies (9 papers). Paula Silverman is often cited by papers focused on Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (20 papers) and Advanced Breast Cancer Therapies (9 papers). Paula Silverman collaborates with scholars based in United States, Canada and France. Paula Silverman's co-authors include Beth Overmoyer, Maryjo Prince‐Paul, Susan Schneider, Clark Distelhorst, Jill Gilbert, Arlene A. Forastiere, Harlan A. Pinto, Yi Li, Cheryl L. Thompson and Laura A. Siminoff and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Paula Silverman

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula Silverman United States 21 901 403 373 306 226 60 1.6k
Miguel Ángel Seguí Spain 22 889 1.0× 444 1.1× 267 0.7× 228 0.7× 115 0.5× 83 1.4k
Helen Krontiras United States 24 829 0.9× 563 1.4× 489 1.3× 181 0.6× 197 0.9× 71 1.7k
Gary V. Burton United States 23 732 0.8× 422 1.0× 209 0.6× 339 1.1× 125 0.6× 68 1.5k
P.F. Bruning Netherlands 21 1.3k 1.4× 522 1.3× 322 0.9× 311 1.0× 238 1.1× 55 2.2k
David A. Decker United States 20 853 0.9× 360 0.9× 231 0.6× 474 1.5× 325 1.4× 57 1.8k
Halle C. F. Moore United States 22 1.0k 1.1× 387 1.0× 202 0.5× 415 1.4× 127 0.6× 88 1.6k
Jacqueline M. Lafky United States 24 1.1k 1.3× 226 0.6× 385 1.0× 251 0.8× 125 0.6× 60 2.0k
Patrick M. Dillon United States 23 1.2k 1.3× 247 0.6× 470 1.3× 368 1.2× 98 0.4× 82 2.1k
Jeffrey B. Smerage United States 19 1.1k 1.3× 904 2.2× 337 0.9× 374 1.2× 188 0.8× 31 1.9k
Leonard Reyno United States 22 694 0.8× 214 0.5× 332 0.9× 503 1.6× 101 0.4× 46 1.6k

Countries citing papers authored by Paula Silverman

Since Specialization
Citations

This map shows the geographic impact of Paula Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Silverman more than expected).

Fields of papers citing papers by Paula Silverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Silverman. The network helps show where Paula Silverman may publish in the future.

Co-authorship network of co-authors of Paula Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Silverman. A scholar is included among the top collaborators of Paula Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Silverman. Paula Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stearns, Vered, Anne O’Neill, Bryan P. Schneider, et al.. (2024). CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108. Breast Cancer Research and Treatment. 209(3). 595–602. 1 indexed citations
2.
Kalra, Maitri, Yan Tong, David Jones, et al.. (2021). Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer. npj Breast Cancer. 7(1). 29–29. 20 indexed citations
3.
Silverman, Paula, et al.. (2020). Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients. Clinical Breast Cancer. 20(5). e551–e554. 4 indexed citations
4.
Harbhajanka, Aparna, Kristy Miskimen, Paula Silverman, et al.. (2018). Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma. Human Pathology. 80. 163–169. 27 indexed citations
5.
Step, Mary M., et al.. (2018). Feasibility of a team based prognosis and treatment goal discussion (T-PAT) with women diagnosed with advanced breast cancer. Patient Education and Counseling. 102(1). 77–84. 2 indexed citations
6.
McGowan, Michelle L., et al.. (2016). “A rising tide lifts all boats”: establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease. BMC Medical Genomics. 9(1). 71–71. 12 indexed citations
7.
8.
Sizemore, Steven T., Gina M. Sizemore, Christine N. Booth, et al.. (2014). Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors. Breast Cancer Research and Treatment. 146(1). 25–40. 27 indexed citations
9.
Silverman, Paula, et al.. (2011). Breast cancer. The Nurse Practitioner. 36(12). 20–26. 34 indexed citations
10.
Gartner, Elaina M., Paula Silverman, Michael S. Simon, et al.. (2011). A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer. Breast Cancer Research and Treatment. 131(3). 933–937. 53 indexed citations
11.
Kim, Janice, Edward Kim, Paula Silverman, et al.. (2010). A Phase II Study of Radiotherapy and Concurrent Paclitaxel Chemotherapy in Breast-Conserving Treatment for Node-Positive Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(1). 14–20. 13 indexed citations
12.
Ellis, Matthew J., Feng Gao, Farrokh Dehdashti, et al.. (2009). Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer. JAMA. 302(7). 774–774. 204 indexed citations
13.
Storniolo, Anna Maria, Mark D. Pegram, Beth Overmoyer, et al.. (2008). Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer. Journal of Clinical Oncology. 26(20). 3317–3323. 89 indexed citations
14.
Siminoff, Laura A., Nahida H. Gordon, Paula Silverman, Thomas Budd, & Peter M. Ravdin. (2006). A decision aid to assist in adjuvant therapy choices for breast cancer. Psycho-Oncology. 15(11). 1001–1013. 83 indexed citations
15.
Gilbert, Jill, Yi Li, Harlan A. Pinto, et al.. (2006). Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group. Head & Neck. 28(3). 197–204. 126 indexed citations
16.
Overmoyer, Beth, et al.. (2005). Pegylated Liposomal Doxorubicin and Cyclophosphamide as First-Line Therapy for Patients with Metastatic or Recurrent Breast Cancer. Clinical Breast Cancer. 6(2). 150–157. 25 indexed citations
17.
Robert, Nicholas J., Charles L. Vogel, I. Craig Henderson, et al.. (2004). The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer. Seminars in Oncology. 31(6 Suppl 13). 106–146. 60 indexed citations
18.
Sparano, Joseph A., et al.. (1996). Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma.. Journal of Clinical Oncology. 14(9). 2576–2583. 5 indexed citations
19.
Silverman, Paula, et al.. (1990). Effect of tumor necrosis factor on the human fibrinolytic system.. Journal of Clinical Oncology. 8(3). 468–475. 12 indexed citations
20.
László, John, et al.. (1983). Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.. PubMed. 67(11). 1009–12. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Ángel Seguí Breakdown of academic impact, for papers by Helen Krontiras Breakdown of academic impact, for papers by Gary V. Burton Breakdown of academic impact, for papers by P.F. Bruning Breakdown of academic impact, for papers by David A. Decker Breakdown of academic impact, for papers by Halle C. F. Moore Breakdown of academic impact, for papers by Jacqueline M. Lafky Breakdown of academic impact, for papers by Patrick M. Dillon Breakdown of academic impact, for papers by Jeffrey B. Smerage Breakdown of academic impact, for papers by Leonard Reyno
Rankless by CCL
2026